4 | SEC Filings Hub

Filing metadata

Accession number: 0001600620-23-000021
Form type: Form 4
Filer: Aurinia Pharmaceuticals Inc.
CIK: CIK 1600620
Filed: May 23, 2023
Reporting period: May 18, 2023
Description: Insider transaction

Documents

0001600620-23-000021-index.htm

Complete submission

0001600620-23-000021.txt

directory listing

Filed by

Aurinia Pharmaceuticals Inc.